Global Longlife Hospital and Research Ltd. Stock Analysis 543520.BO

Global Longlife Hospital & Research Ltd. operates as a multi-specialty tertiary care hospital. The company is headquartered in Ahmedabad, Gujarat and currently employs 6 full-time employees. The company went IPO on 2022-05-04. The firm offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gastrointestinal (GI) medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cardiovascular thoracic surgery (CVTS), joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery, ear, nose, and throat (ENT), plastic surgery, trauma center, urology, laparoscopic surgery, gynecology, and more. Its radiology services include mammography, CT scan, ultrasound, endoscopy, and sonography. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.